232 related articles for article (PubMed ID: 30387805)
21. Resveratrol inhibits proliferation and migration through SIRT1 mediated post‑translational modification of PI3K/AKT signaling in hepatocellular carcinoma cells.
Chai R; Fu H; Zheng Z; Liu T; Ji S; Li G
Mol Med Rep; 2017 Dec; 16(6):8037-8044. PubMed ID: 28983625
[TBL] [Abstract][Full Text] [Related]
22. Sirtuin 6 inhibits colon cancer progression by modulating PTEN/AKT signaling.
Tian J; Yuan L
Biomed Pharmacother; 2018 Oct; 106():109-116. PubMed ID: 29957460
[TBL] [Abstract][Full Text] [Related]
23. Quinalizarin exerts an anti-tumour effect on lung cancer A549 cells by modulating the Akt, MAPK, STAT3 and p53 signalling pathways.
Meng LQ; Liu C; Luo YH; Piao XJ; Wang Y; Zhang Y; Wang JR; Wang H; Xu WT; Liu Y; Wu YQ; Sun HN; Han YH; Jin MH; Shen GN; Zang YQ; Li J; Fang NZ; Cui YD; Jin CH
Mol Med Rep; 2018 Feb; 17(2):2626-2634. PubMed ID: 29207064
[TBL] [Abstract][Full Text] [Related]
24. Resveratrol inhibits human nasopharyngeal carcinoma cell growth via blocking pAkt/p70S6K signaling pathways.
Zhang M; Zhou X; Zhou K
Int J Mol Med; 2013 Mar; 31(3):621-7. PubMed ID: 23314035
[TBL] [Abstract][Full Text] [Related]
25. Resveratrol induces cell cycle arrest in human gastric cancer MGC803 cells via the PTEN-regulated PI3K/Akt signaling pathway.
Jing X; Cheng W; Wang S; Li P; He L
Oncol Rep; 2016 Jan; 35(1):472-8. PubMed ID: 26530632
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of Rac1 activity induces G1/S phase arrest through the GSK3/cyclin D1 pathway in human cancer cells.
Liu L; Zhang H; Shi L; Zhang W; Yuan J; Chen X; Liu J; Zhang Y; Wang Z
Oncol Rep; 2014 Oct; 32(4):1395-400. PubMed ID: 25109327
[TBL] [Abstract][Full Text] [Related]
27. shRNA-induced silencing of Ras-related C3 botulinum toxin substrate 1 inhibits the proliferation of colon cancer cells through upregulation of BAD and downregulation of cyclin D1.
Huang YS; Jie N; Zhang YX; Zou KJ; Weng Y
Int J Mol Med; 2018 Mar; 41(3):1397-1408. PubMed ID: 29286138
[TBL] [Abstract][Full Text] [Related]
28. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells.
Shimizu M; Deguchi A; Lim JT; Moriwaki H; Kopelovich L; Weinstein IB
Clin Cancer Res; 2005 Apr; 11(7):2735-46. PubMed ID: 15814656
[TBL] [Abstract][Full Text] [Related]
29. M
Peng Y; Qiu L; Xu D; Zhang L; Yu H; Ding Y; Deng L; Lin J
Life Sci; 2017 Sep; 185():63-72. PubMed ID: 28751160
[TBL] [Abstract][Full Text] [Related]
30. Vorinostat Enhances Cytotoxicity of SN-38 and Temozolomide in Ewing Sarcoma Cells and Activates STAT3/AKT/MAPK Pathways.
Sampson VB; Vetter NS; Kamara DF; Collier AB; Gresh RC; Kolb EA
PLoS One; 2015; 10(11):e0142704. PubMed ID: 26571493
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of microRNA‑21 expression inhibits proliferation, and induces G1 arrest and apoptosis via the PTEN/AKT pathway in SKM‑1 cells.
Li G; Song Y; Li G; Ren J; Xie J; Zhang Y; Gao F; Mu J; Dai J
Mol Med Rep; 2018 Sep; 18(3):2771-2779. PubMed ID: 30015844
[TBL] [Abstract][Full Text] [Related]
32. Only Akt1 is required for proliferation, while Akt2 promotes cell cycle exit through p21 binding.
Héron-Milhavet L; Franckhauser C; Rana V; Berthenet C; Fisher D; Hemmings BA; Fernandez A; Lamb NJ
Mol Cell Biol; 2006 Nov; 26(22):8267-80. PubMed ID: 16982699
[TBL] [Abstract][Full Text] [Related]
33. PAC exhibits potent anti-colon cancer properties through targeting cyclin D1 and suppressing epithelial-to-mesenchymal transition.
Al-Qasem A; Al-Howail HA; Al-Swailem M; Al-Mazrou A; Al-Otaibi B; Al-Jammaz I; Al-Khalaf HH; Aboussekhra A
Mol Carcinog; 2016 Mar; 55(3):233-44. PubMed ID: 25641341
[TBL] [Abstract][Full Text] [Related]
34. Scutellaria barbata D. Don induces G1/S arrest via modulation of p53 and Akt pathways in human colon carcinoma cells.
Wei L; Lin J; Wu G; Xu W; Li H; Hong Z; Peng J
Oncol Rep; 2013 Apr; 29(4):1623-8. PubMed ID: 23354912
[TBL] [Abstract][Full Text] [Related]
35. Ribozymes targeting serine/threonine kinase Akt1 sensitize cells to anticancer drugs.
Yanagihara M; Katano M; Takahashi-Sasaki N; Kimata K; Taira K; Andoh T
Cancer Sci; 2005 Sep; 96(9):620-6. PubMed ID: 16128748
[TBL] [Abstract][Full Text] [Related]
36. Alpinetin inhibits proliferation and migration of ovarian cancer cells via suppression of STAT3 signaling.
Zhao X; Guo X; Shen J; Hua D
Mol Med Rep; 2018 Oct; 18(4):4030-4036. PubMed ID: 30132572
[TBL] [Abstract][Full Text] [Related]
37. Resveratrol eliminates cancer stem cells of osteosarcoma by STAT3 pathway inhibition.
Peng L; Jiang D
PLoS One; 2018; 13(10):e0205918. PubMed ID: 30356255
[TBL] [Abstract][Full Text] [Related]
38. Curcumin inhibits growth potential by G1 cell cycle arrest and induces apoptosis in p53-mutated COLO 320DM human colon adenocarcinoma cells.
Dasiram JD; Ganesan R; Kannan J; Kotteeswaran V; Sivalingam N
Biomed Pharmacother; 2017 Feb; 86():373-380. PubMed ID: 28011386
[TBL] [Abstract][Full Text] [Related]
39. JQ1 suppresses tumor growth via PTEN/PI3K/AKT pathway in endometrial cancer.
Qiu H; Li J; Clark LH; Jackson AL; Zhang L; Guo H; Kilgore JE; Gehrig PA; Zhou C; Bae-Jump VL
Oncotarget; 2016 Oct; 7(41):66809-66821. PubMed ID: 27572308
[TBL] [Abstract][Full Text] [Related]
40. Piperine, an alkaloid from black pepper, inhibits growth of human colon cancer cells via G1 arrest and apoptosis triggered by endoplasmic reticulum stress.
Yaffe PB; Power Coombs MR; Doucette CD; Walsh M; Hoskin DW
Mol Carcinog; 2015 Oct; 54(10):1070-85. PubMed ID: 24819444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]